FdaApplication
NDA 219685
Identifiers
- fda_app_no: NDA219685
Properties
| Property | Value |
|---|---|
| applicant_name | GENZYME CORP |
| application_type | NDA |
| approval_date | 2025-08-29 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| WAYRILZ | RILZABRUTINIB | 400MG | TABLET;ORAL |
1 product